Canada Infection Control Market - Forecasts from 2020 to 2025
Canada infection control market is projected to grow at a CAGR of 7.26% during the forecast period. A rise in the aging demographics and a surge in chronic conditions amongst Canadians together with increased turnover of hospital rooms has necessitated the Canadian healthcare sector to equip itself with a range of Infection Control products in Canada. A decent proportion of patients who are receiving healthcare in Canada gets infected every year due to what The World Health Organization (WHO) defines as nosocomial infections. This requires the infection prevention procedures to be even more stringent and rigorous. Therefore, to be in tandem with the healthcare industry Clorox Healthcare Canada that offers a portfolio of surface cleaner-disinfectants, in addition to UV technology, to provide healthcare facilities with a comprehensive approach to environmental hygiene in efforts to prevent hospital-borne infections, has bolstered its research surrounding microbiology, sporicidal agents and infection prevention. This has resulted in a stream of innovative new products specifically for the hospital environment including Clorox Healthcare® Hydrogen Peroxide Cleaner Disinfectant Wipes, Clorox Healthcare® Bleach Germicidal Wipes and Clorox Healthcare® Fusion™ Cleaner
Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.
Further, another factor that is poised set an upward trend for Canadian Infection Control Market the increasing use of sanitizers both in residential premises as well as in healthcare points. Plus, due to the growing number of surgeries, the total number stays in the hospitals is also increasing creating a high chance of contracting an infection. This necessitates an active adherence to sterilization and disinfection procedures in various kinds of healthcare points throughout the country. Further due to stringent regulatory compliance and inclusion of technically enhanced instruments there has been a growing need for advanced sterilizers that tailor-made for these devices which in turn is leading to more investment in research and development that has led to the growing adoption of low-temperature sterilizers with its wide range of technologies such as ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization. TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices announced it has entered in into a binding US$20 million debt financing with Courage Capital Management LLC, an investment advisor to fund commercialization initiatives for TSO3’s STERIZONE® VP4 Sterilizer, the only terminal sterilization method that is FDA cleared to sterilize multi-channeled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as certain colonoscopes, gastroscopes, and duodenoscopes. Therefore, it could be discerned with certainty that the aforementioned agreements and launch are the result of the increasing need for infection control devices which is poised to fuel the Canada Infection Control Market during the forecast period.
Segmentation
Disinfectant, a next-generation bleach product combining disinfecting efficacy against pathogens with broad surface compatibility.
Further, another factor that is poised set an upward trend for Canadian Infection Control Market the increasing use of sanitizers both in residential premises as well as in healthcare points. Plus, due to the growing number of surgeries, the total number stays in the hospitals is also increasing creating a high chance of contracting an infection. This necessitates an active adherence to sterilization and disinfection procedures in various kinds of healthcare points throughout the country. Further due to stringent regulatory compliance and inclusion of technically enhanced instruments there has been a growing need for advanced sterilizers that tailor-made for these devices which in turn is leading to more investment in research and development that has led to the growing adoption of low-temperature sterilizers with its wide range of technologies such as ethylene oxide (EtO), vaporized hydrogen peroxide (VHP), hydrogen peroxide gas plasma, and ozone gas-based sterilization. TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices announced it has entered in into a binding US$20 million debt financing with Courage Capital Management LLC, an investment advisor to fund commercialization initiatives for TSO3’s STERIZONE® VP4 Sterilizer, the only terminal sterilization method that is FDA cleared to sterilize multi-channeled flexible endoscopes (with a maximum of four channels) of up to 3.5 meters in length, such as certain colonoscopes, gastroscopes, and duodenoscopes. Therefore, it could be discerned with certainty that the aforementioned agreements and launch are the result of the increasing need for infection control devices which is poised to fuel the Canada Infection Control Market during the forecast period.
Segmentation
- By Product
- Disinfectants
- Sterilization
- Low-Temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. CANADA INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectants
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. CANADA INFECTION CONTROL MARKET, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Cantel (Canada) Inc.
8.3. Ecolab
8.4. Metrex Research Corporation
8.5. STERIS plc
8.6. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. CANADA INFECTION CONTROL MARKET, BY PRODUCT
5.1. Introduction
5.2. Disinfectants
5.3. Sterilization
5.3.1. Low-Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. CANADA INFECTION CONTROL MARKET, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. Cantel (Canada) Inc.
8.3. Ecolab
8.4. Metrex Research Corporation
8.5. STERIS plc
8.6. List is not Exhaustive*
